drugset / Trial / NCT00185484
Efficacy and Safety Oral Contraceptive Study
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether the study drug is effective in prevention of pregnancy in healthy women in reproductive age
Timeline
- Start
- 2004-03
- Primary completion
- —
- Completion
- 2006-01
Publications
- Results Anttila L, Neunteufel W, Petraglia F, Marr J, Kunz M. Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 mug compared with a 21/7 regimen of desogestrel 150 mug/ethinylestradiol 20 mug: a pooled analysis. Clin Drug Investig. 2011;31(8):519-525. doi: 10.2165/11590260-000000000-00000.
- Results Anttila L, Bachmann G, Hernadi L, Kunz M, Marr J, Klipping C. Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 mug/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies. Eur J Obstet Gynecol Reprod Biol. 2011 Apr;155(2):180-2. doi: 10.1016/j.ejogrb.2010.12.037. Epub 2011 Feb 1.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | drospirenone | Unknown | 3 mg | — |
| Subject | ethinyl estradiol | Small molecule | 0.02 mg | — |
Indications
No indication recorded.